Title

Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients.

Document Type

Article

Publication Date

2-1-2015

Institution/Department

Urology

Journal Title

Urology

MeSH Headings

Aged, Aged, 80 and over, Cost of Illness, Hospice Care, Humans, Male, Middle Aged, Patient Admission, Prostatic Neoplasms

ISSN

1527-9995

Abstract

OBJECTIVE: To examine the rates of hospitalization in patients with metastatic prostate cancer (mCaP), as well as the effect of hospice utilization on the cost patterns of mCaP. Over the past decade, dramatic changes in the management of advanced prostate cancer have proceeded alongside changes in end-of-life care. But, the impact of these contemporary advances in management of mCaP and its implications on US health care expenditure remains unknown.

METHODS: Patients hospitalized with mCaP from 1998 to 2010 were extracted from the Nationwide Inpatient Sample (n = 100,220). Temporal trends in incidence and charges were assessed by linear regression. Complex samples logistic regression models were used to identify the predictors of in-hospital mortality, elevated hospital charges beyond the 75th percentile and hospice utilization.

RESULTS: Between 1998 and 2010, admissions for mCaP decreased at a rate of -5.95% per year (P

CONCLUSION: Despite a decline in hospitalizations for mCaP, the economic burden of care has remained stable. Increasing use of hospice services has moderated the effect of rising per-incident hospital charges, highlighting the importance of promoting access to hospice in the right clinical setting. These findings have important policy implications, particularly as advances in treatment are expected to further increase expenditures related to the inpatient management of mCaP.

First Page

343

Last Page

349

Share

COinS